Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperhidrosis, Hypersensitivity, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Pain in heart; Numbness in tongue; Numbness in feet; Uncontrollably sweating; Tingling; Shortness of breath/Hard to breathe; Chest pain; Depression; certain sexual functions are more painful; Pain throughout his body; allergic reaction to the vaccine; Fever of almost 105 degrees; Calcification of spleen; Calcification of the lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of ANGINA PECTORIS (Pain in heart), HYPOAESTHESIA ORAL (Numbness in tongue), HYPOAESTHESIA (Numbness in feet), HYPERHIDROSIS (Uncontrollably sweating) and PARAESTHESIA (Tingling) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced SPLENIC CALCIFICATION (Calcification of spleen) and LYMPH NODE CALCIFICATION (Calcification of the lymph nodes). On 10-Sep-2021, the patient experienced HYPOAESTHESIA ORAL (Numbness in tongue), HYPOAESTHESIA (Numbness in feet), HYPERHIDROSIS (Uncontrollably sweating), PARAESTHESIA (Tingling), DYSPNOEA (Shortness of breath/Hard to breathe), CHEST PAIN (Chest pain), DEPRESSION (Depression), DYSPAREUNIA (certain sexual functions are more painful), PAIN (Pain throughout his body), HYPERSENSITIVITY (allergic reaction to the vaccine) and PYREXIA (Fever of almost 105 degrees). On 12-Sep-2021, the patient experienced ANGINA PECTORIS (Pain in heart). The patient was treated with COLCHICINE at a dose of 5 mg twice a day; ESCITALOPRAM OXALATE (LEXAPRO) at a dose of 10 mg once a day and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 500 mg three times a day. At the time of the report, ANGINA PECTORIS (Pain in heart), HYPOAESTHESIA ORAL (Numbness in tongue), HYPOAESTHESIA (Numbness in feet), HYPERHIDROSIS (Uncontrollably sweating), PARAESTHESIA (Tingling), DYSPNOEA (Shortness of breath/Hard to breathe), CHEST PAIN (Chest pain), DEPRESSION (Depression), DYSPAREUNIA (certain sexual functions are more painful), SPLENIC CALCIFICATION (Calcification of spleen), LYMPH NODE CALCIFICATION (Calcification of the lymph nodes), PAIN (Pain throughout his body), HYPERSENSITIVITY (allergic reaction to the vaccine) and PYREXIA (Fever of almost 105 degrees) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: calcifications of the lymph nodes and spleen. (abnormal) Calcifications of the lymph nodes and spleen..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product was provided. It was reported that patient had allergic reaction to the vaccine and had been seeing a doctor for two months. He stated he received the vaccination in his arm where he normally received his flu shot. He reported he had pain in his heart about 48 hours after receiving the injection. The day of the vaccination he developed numbness in this tongue and feet. He experienced tingling. He had a fever of almost 105 degrees was uncontrollably sweating and had pain throughout his body. He also had shortness of breath, chest pain, depression and certain sexual functions were more painful. The caller stated he had a computed tomography scan date was unknown at the time of the call and the results were calcifications of the lymph nodes and spleen. He stated will be seeing a pulmonologist because it was hard to breathe.  Cardiac Lab values (ECG, cardiac test, cardiac enzymes)- The caller states knows he has had labs, but did not know the specifics other than his numbers are going down.   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: Follow up received wherein new reporters, patient demographics, treatment drugs  and new events were added.